Shanghai Jahwa, the venerable titan of Chinese personal care, recently unveiled its first full-year results under the leadership of Chairman Lin Xiaohai. On the surface, the numbers for 2025 suggest a dramatic turnaround for the firm behind the ubiquitous Liushen and Herborist brands. Revenue climbed 11.25% to 6.32 billion yuan, effectively snapping a four-year losing streak and returning the company to a net profit of 268 million yuan after a staggering loss in 2024.
However, a closer inspection of the balance sheet reveals a recovery built more on financial engineering than consumer demand. Of the 268 million yuan in net profit, a remarkable 223 million yuan—nearly 80%—was derived from non-recurring gains, primarily through fund investments and fair value adjustments. When stripped of these one-off windfalls, the company’s core business operations generated a meager 45 million yuan, representing a paper-thin net margin of just 0.7%.
The structural challenges facing the company are most evident in its core 'Personal Care' segment. Liushen, the cooling floral water that has defined Chinese summers for decades, saw growth virtually stall at 1.65%. While the newer 'Beauty' segment, led by the dermatology-focused Yuze, surged by 53.7%, this growth came at an unsustainable cost. The company’s marketing expenses grew faster than its revenue, with nearly 48 yuan out of every 100 yuan earned being poured back into advertising and traffic acquisition.
This reliance on high-octane marketing was particularly painful in the fourth quarter, coinciding with China’s 'Double 11' shopping festival. Despite the seasonal sales surge, Shanghai Jahwa recorded a loss of 138 million yuan for the quarter as marketing costs spiked to 52.3% of revenue. This cycle of buying growth through expensive digital traffic highlights the difficulty legacy brands face in an era where platform algorithms, rather than brand loyalty, increasingly dictate market share.
Furthermore, the company’s international ambitions remain a significant drag on performance. Tommee Tippee, the UK-based baby care brand acquired in 2017, continues to struggle against a backdrop of declining global birth rates and rising trade tensions in North America. Its overseas subsidiary reported a net loss for 2025, suggesting that the brand has yet to find its footing after years of goodwill impairments and macroeconomic volatility.